Pharmaceuticals, Biotechnology and Life Sciences
– Risdiplam demonstrated statistically significant and medically meaningful motor milestone improvement in infants with Type 1 SMA – – No…
WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of…
LONDON–(BUSINESS WIRE)–#Biotechnology–Technavio has been monitoring the global heparin market since 2015 and the market is poised to grow by USD…
— Phase 3 trial achieved its primary endpoint and all secondary endpoints with marked improvement in key indicators of disease…
WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of…
WASHINGTON–(BUSINESS WIRE)–#GovWaste–Today, Citizens Against Government Waste (CAGW) named California Governor Gavin Newsom our January 2020 Porker of the Month for…
CEO Sandy Solmon to Present on Celavie’s Stem Cell Therapies at Upcoming Conferences in New York and Barcelona OXNARD, Calif.–(BUSINESS…
CEO Sandy Solmon to Present on Celavie’s Stem Cell Therapies at Upcoming Conferences in New York and Barcelona OXNARD, Calif.–(BUSINESS…
– Settlement with Teva represents final outstanding LINZESS patent litigation – – The earliest licensed entry of any generic linaclotide…
Company to Initiate First U.S. Clinical Investigation of Allogeneic NK Cell Therapy administered Intravenously or Intratumorally in Patients with Glioblastoma…